Oncology Pharma Inc.
ONPH · OTC
3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $9 | $2 | $7 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $4 | $9 | $2 | $7 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2,119 | $339 | $228 | $182 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2,119 | $339 | $229 | $184 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,123 | $348 | $231 | $191 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $662 | $238 | $129 | $238 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $213 | $279 | $165 | $165 |
| Total Curr. Liab. | $875 | $518 | $295 | $403 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $875 | $518 | $295 | $403 |
| Equity | – | – | – | – |
| Pref Stock | $1 | $1 | $1 | $1 |
| Common Stock | $189 | $182 | $150 | $125 |
| Retained Earnings | -$272,099 | -$167,472 | -$69,999 | -$69,792 |
| AOCI | -$189 | -$182 | -$150 | $100 |
| Other Equity | $273,345 | $167,301 | $69,935 | $69,353 |
| Total Equity | $1,247 | -$170 | -$64 | -$213 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,123 | $348 | $231 | $191 |
| Net Debt | $658 | $229 | $128 | $231 |